BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28060133)

  • 1. Secondary Hemophagocytic Lymphohistiocytosis: Do We Really Need Chemotherapeutics for All Patients?
    Haytoglu Z; Yazici N; Erbay A
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e106-e109. PubMed ID: 28060133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis.
    Amir AZ; Ling SC; Naqvi A; Weitzman S; Fecteau A; Grant D; Ghanekar A; Cattral M; Nalli N; Cutz E; Kamath B; Jones N; De Angelis M; Ng V; Avitzur Y
    Liver Transpl; 2016 Sep; 22(9):1245-53. PubMed ID: 27216884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
    Castillo L; Carcillo J
    Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
    Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
    Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary haemophagocytic lymphohistiocytosis: Experience from the Uppsala University Hospital.
    Karlsson T
    Ups J Med Sci; 2015; 120(4):257-62. PubMed ID: 26212358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
    Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
    Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis.
    Otrock ZK; Eby CS
    Am J Hematol; 2015 Mar; 90(3):220-4. PubMed ID: 25469675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis.
    Otrock ZK; Hock KG; Riley SB; de Witte T; Eby CS; Scott MG
    Ann Hematol; 2017 Oct; 96(10):1667-1672. PubMed ID: 28762079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience.
    Lorenz F; Klimkowska M; Pawłowicz E; Bulanda Brustad A; Erlanson M; Machaczka M
    Leuk Lymphoma; 2018 Aug; 59(8):1840-1850. PubMed ID: 29295642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
    Naymagon L; Tremblay D; Mascarenhas J
    Eur J Haematol; 2020 Apr; 104(4):344-351. PubMed ID: 31991015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan.
    Asano T; Kogawa K; Morimoto A; Ishida Y; Suzuki N; Ohga S; Kudo K; Ohta S; Wakiguchi H; Tabuchi K; Kato S; Ishii E
    Pediatr Blood Cancer; 2012 Jul; 59(1):110-4. PubMed ID: 22038983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for early death in children with haemophagocytic lymphohistiocytosis.
    Trottestam H; Berglöf E; Horne A; Onelöv E; Beutel K; Lehmberg K; Sieni E; Silfverberg T; Aricò M; Janka G; Henter JI
    Acta Paediatr; 2012 Mar; 101(3):313-8. PubMed ID: 22017632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperferritinemia as the diagnostic clue in life-threatening hemophagocytic lymphohistiocytosis.
    Kerzel S; Zemlin M; Kömhoff M; Klaus G; Maier RF
    Klin Padiatr; 2009 Sep; 221(5):318-21. PubMed ID: 19199227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.
    Trottestam H; Horne A; Aricò M; Egeler RM; Filipovich AH; Gadner H; Imashuku S; Ladisch S; Webb D; Janka G; Henter JI;
    Blood; 2011 Oct; 118(17):4577-84. PubMed ID: 21900192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study.
    Mottaghipisheh H; Kalantar K; Amanati A; Shokripour M; Shahriari M; Zekavat OR; Zareifar S; Karimi M; Haghpanah S; Bordbar M
    BMC Infect Dis; 2021 Aug; 21(1):732. PubMed ID: 34340686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults.
    Daver N; McClain K; Allen CE; Parikh SA; Otrock Z; Rojas-Hernandez C; Blechacz B; Wang S; Minkov M; Jordan MB; La Rosée P; Kantarjian HM
    Cancer; 2017 Sep; 123(17):3229-3240. PubMed ID: 28621800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial and acquired hemophagocytic lymphohistiocytosis.
    Janka G; zur Stadt U
    Hematology Am Soc Hematol Educ Program; 2005; ():82-8. PubMed ID: 16304363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
    Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
    BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.